Related Experiment Video
Updated: Jun 5, 2026

Dual Bioluminescence Imaging of Tumor Progression and Angiogenesis
Published on: August 1, 2019
Direct inhibitory effects of Ganciclovir on ICAM-1 expression and proliferation in human coronary vascular cells
Rainer Voisard1, Ulrike Münder, Lutz von Müller
1Department of Internal Medicine II-Cardiology, University of Ulm, Ulm, Germany. rainer@voisard.de
Background:
Treatment of the human cytomegalovirus (HCMV) infection with ganciclovir has beneficial indirect effects on the complex interactions of HCMV with restenosis, atherosclerosis, and transplant vascular sclerosis. The current study reports on direct effects of ganciclovir on expression of ICAM-1 and cell proliferation, key events of coronary atherosclerosis/restenosis. A potential clinical relevance of the data will be evaluated with the help of SI/MPL-ratio's.
Material/Methods:
Definition of the SI/MPL-ratio: relation between significant inhibitory effects in vitro/ex vivo and the maximal plasma level after systemic administration in vivo (ganciclovir: 9 µg/ml). Part I of the study investigated in cytoflow studies the effect of ganciclovir (0.05-5000 µg/mL) on TNF-a induced expression of intercellular adhesion molecule 1 (ICAM-1) in endothelial cells derived from umbilical veins (HUVEC), human coronary endothelial cells (HCAEC), and human coronary smooth muscle cells (HCMSMC). Part II of the study analysed the effect of ganciclovir (0.05-5000 µg/mL) on cell proliferation (HUVEC, HCAEC, and HCMSMC). In part III cytotoxic effects of ganciclovir (0.05-5000 µg/mL) were studied (HUVEC, HCAEC, and HCMSMC).
Results:
Ganciclovir caused slight but significant inhibitory effects on expression of ICAM-1 in HUVEC, HCAEC, and HCMSMC. In all three cell types studied strong dose depending significant antiproliferative effects of ganciclovir were detected. Partially, the antiproliferative effects of ganciclovir were caused by cytotoxic effects.
Conclusions:
SI/MPL-ratio's >1 in HCAEC and HCMSMC indicate that the inhibitory effects of gancliclovir on ICAM-1-expression and cell proliferation may only be expected in vivo following local high dose administration e.g. in drug eluting stents (DES).
Insights
Ganciclovir shows antiproliferative effects on coronary cells, partially due to cytotoxicity. Its impact on ICAM-1 expression and cell proliferation may be relevant in vivo for drug-eluting stents.
Area of Science:
- Cardiovascular Research
- Virology
- Pharmacology
Background:
- Human cytomegalovirus (HCMV) infection influences cardiovascular conditions like restenosis and atherosclerosis.
- Ganciclovir treatment for HCMV infection has indirect benefits on these conditions.
- This study investigates the direct effects of ganciclovir on key factors in coronary atherosclerosis.
Purpose of the Study:
- To evaluate the direct impact of ganciclovir on intercellular adhesion molecule 1 (ICAM-1) expression.
- To assess the direct impact of ganciclovir on endothelial and smooth muscle cell proliferation.
- To determine the clinical relevance of ganciclovir's effects using SI/MPL-ratios.
Main Methods:
- In vitro studies using cytoflow analysis on human umbilical vein endothelial cells (HUVEC), human coronary artery endothelial cells (HCAEC), and human coronary smooth muscle cells (HCMSMC).
- Ganciclovir was administered at concentrations ranging from 0.05 to 5000 µg/mL.
- Assessed TNF-α induced ICAM-1 expression, cell proliferation, and cytotoxic effects.
Main Results:
- Ganciclovir exhibited slight but significant inhibition of ICAM-1 expression in all tested cell types.
- Dose-dependent and significant antiproliferative effects of ganciclovir were observed across all cell types.
- Cytotoxic effects partially contributed to the observed antiproliferative actions of ganciclovir.
Conclusions:
- SI/MPL-ratios greater than 1 in HCAEC and HCMSMC suggest that ganciclovir's inhibitory effects on ICAM-1 and proliferation may occur in vivo.
- These effects are likely relevant only with high local drug concentrations, such as those delivered by drug-eluting stents (DES).
- Ganciclovir's direct cellular effects warrant consideration in the context of cardiovascular interventions.
More Related Videos
07:22A High-throughput Cre-Lox Activated Viral Membrane Fusion Assay to Identify Inhibitors of HIV-1 Viral Membrane Fusion
Published on: August 14, 2018
08:00Enhancing the Engraftment of Human Induced Pluripotent Stem Cell-derived Cardiomyocytes via a Transient Inhibition of Rho Kinase Activity
Published on: July 10, 2019
Related Concept Videos
Antiviral Nucleoside Inhibitors
Immunoglobulin-like Cell Adhesion Molecules
Ig-CAMs exhibit either homophilic binding (to other Ig-CAMs) or heterophilic binding (to other ligands such as integrins). While most Ig-CAMs...
Cytomegalovirus Disease
Inhibition of CDK Activity
Inhibition of Cdk Activity